Item request has been placed!

Item request cannot be made.

Processing Request

Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic.

Item request has been placed!

Item request cannot be made.

Processing Request

Read More Add to Saved list

Author(s): de Paula BHR;de Paula BHR; Araújo I; Araújo I; Bandeira L; Bandeira L; Barreto NMPB; Barreto NMPB; Doherty GJ; Doherty GJ
Source:
The Lancet. Oncology [Lancet Oncol] 2020 May; Vol. 21 (5), pp. 624-627. Date of Electronic Publication: 2020 Apr 08.
Publication Type:
Journal Article
Language:
English

Additional Information
- Source:
  Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
- Publication Information:
  Original Publication: London : Lancet Pub. Group, c2000-
- Subject Terms:
  Clinical Trials as Topic*; Coronavirus Infections/*epidemiology ; Neoplasms/*therapy ; Pneumonia, Viral/*epidemiology; COVID-19 ; Colombia ; Government Agencies ; Humans ; Norway ; Pandemics ; United Kingdom ; United States ; United States Food and Drug Administration
- References:
  J Natl Cancer Inst. 2019 Mar 1;111(3):245-255. (PMID: 30856272)
  Ann Oncol. 2019 Nov 1;30(11):1694-1696. (PMID: 31501860)
- Publication Date:
  Date Created: 20200412 Date Completed: 20200506 Latest Revision: 20210110
- Publication Date:
  20240105
- Accession Number:
  PMC7252196
- Accession Number:
  10.1016/S1470-2045(20)30226-6
- Accession Number:
  32277907

Comments

No Comments.